SARS-CoV-2 enhances lysosomal exocytosis and deacidifies lysosomes to facilitate viral releaseOA
The mechanism of SARS-CoV-2 egress predominantly governs the quantity and quality of progeny viruses,thereby significantly contributing to viral pathogenicity.However,the key factors influencing viral egress remain largely unclear.In this study,using transcription-and replication-competent SARS-CoV-2 virus-like-particle(SARS-CoV-2 trVLP),electron microscopy,drug inhibition assays,and cellular pH-sensitive fluorescent probes,we demonstrate that increased lysosomal exocytosis efficiency and lysosome deacidification play a pivotal role in facilitating SARS-CoV-2 egress.Specifically,SARSCoV-2 may use multiple egress pathways,with lysosomal exocytosis as the primary mechanism and the biosynthetic secretory pathway as a less efficient route.Viral infection enhances lysosomal exocytosis via the ORF3a protein,thus facilitating viral release.SARS-CoV-2 infection also induces lysosome deacidification;moreover,treatment with bafilomycin A1,which induces lysosome deacidification,further enhances viral egress.Furthermore,we systematically investigate how viral proteins affect lysosomal pH and enzymatic activities.Our findings reveal that ORF3a and E proteins induce lysosome deacidification and diminish lysosomal enzyme activities,probably protecting progeny viruses from premature cleavage and degradation.This study provides mechanistic insight into how SARS-CoV-2 promotes lysosomal exocytosis and triggers lysosome deacidification for viral release.
Fujun Qin;Chuang Yan;Zizheng Liu;Dianbing Wang;Huimin Zhong;Qiang Ding;Minghai Chen;Xian-En Zhang
State Key Laboratory of Quantitative Synthetic Biology,Shenzhen Institute of Synthetic Biology,Shenzhen Institutes of Advanced Technology,Chinese Academy of Sciences,Shenzhen,ChinaState Key Laboratory of Quantitative Synthetic Biology,Shenzhen Institute of Synthetic Biology,Shenzhen Institutes of Advanced Technology,Chinese Academy of Sciences,Shenzhen,ChinaState Key Laboratory of Biomacromolecules,Institute of Biophysics,Chinese Academy of Sciences,Beijing,ChinaState Key Laboratory of Biomacromolecules,Institute of Biophysics,Chinese Academy of Sciences,Beijing,ChinaState Key Laboratory of Quantitative Synthetic Biology,Shenzhen Institute of Synthetic Biology,Shenzhen Institutes of Advanced Technology,Chinese Academy of Sciences,Shenzhen,ChinaSchool of Medicine,Tsinghua University,Beijing,ChinaState Key Laboratory of Quantitative Synthetic Biology,Shenzhen Institute of Synthetic Biology,Shenzhen Institutes of Advanced Technology,Chinese Academy of Sciences,Shenzhen,ChinaFaculty of Synthetic Biology,Shenzhen University of Advanced Technology,Shenzhen,China State Key Laboratory of Biomacromolecules,Institute of Biophysics,Chinese Academy of Sciences,Beijing,China
医药卫生
lysosomal exocytosislysosome deacidificationORF3a proteinSARS-CoV-2synthetic biology
《mLife》 2026 (3)
P.339-354,16
supported by the National Key R&D Program of China(Grant No.2022YFC2303500)the Strategic Priority Research Program of the Chinese Academy of Sciences(Grant No.XDB29050100)the National Natural Science Foundation of China(Grant Nos.32100121,32101210,and 21890743).
评论